LoginRegister
    Trump administration drug officials clash over how to combat fentanyl copycatsTrump administration drug officials clash over how to combat fentanyl copycats
    Difference of 50-90 percent in prices of Branded and Generic medicines- Minister informs ParliamentDifference of 50-90 percent in prices of Branded and Generic medicines- Minister informs Parliament
    Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitorSun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor
    USFDA approves Glenmark Pharma anti-anginal drug Ranolazine ER TabletsUSFDA approves Glenmark Pharma anti-anginal drug Ranolazine ER Tablets
    Bayer seeks approval for blockbuster Xarelto to treat thromboembolism in childrenBayer seeks approval for blockbuster Xarelto to treat thromboembolism in children
    UK hopes to prevent 100000 cancer cases; HPV vaccines will be rolled out to boysUK hopes to prevent 100000 cancer cases; HPV vaccines will be rolled out to boys
    Oklahoma judge denies motion to end case against drugmaker JnJOklahoma judge denies motion to end case against drugmaker JnJ
    Drug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; DetailsDrug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; Details
    Biocon gets dozen USFDA observations for 3 units in MalaysiaBiocon gets dozen USFDA observations for 3 units in Malaysia
    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategyDr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy
    Solara Cuddalore facility successfully completes USFDA inspectionSolara Cuddalore facility successfully completes USFDA inspection
    City council reviews use of Bayer Roundup weed killer amid cancer fearsCity council reviews use of Bayer Roundup weed killer amid cancer fears
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X